Heramed Ltd (hmd) Logo

Heramed Ltd (HMD)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

HMD ASX Chart

Snapshot

HERAMED Limited (HMD) is focused on the commercialization and deployment of HeraCARE pregnancy monitoring solution. The company has generated revenue related to the provision of pregnancy monitoring services under key contracts with customers through the delivery of their HeraCARE software platform and HeraBEAT monitoring devices.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -75.28%
vs ASX 200 (1yr) -85.78%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,990 of 2,382
Sector Rank 193 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies MEB / ILA / IXC
EPS -$0.016
DPS $0.00
Book Value Per Share $0.005

Broker Consensus

HMD is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Camberwell VIC 3124
Website www.hera-med.com
Registry Xcend Pty Ltd
Auditor BDO Audit (WA) Pty Ltd
Date Listed 12 Dec 2018

Upcoming Calendar (Forecasted)

Date Event
16/08/2024 Report (Interim)
27/02/2025 Report (Prelim)
27/03/2025 Report (Annual)

Former Company Names

  • Heramed Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

HMD directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
28/03/24 David Hinton Issued 71,667 $0.020 $1,433 Rights issue
09/10/23 Ronald (Ron) Weinberger Issued 7,500,000 $0.062 $465,000 Issue of options
23/03/23 Ronald (Ron) Weinberger Buy +215,000 $0.114 $24,553 On-market trade
07/12/21 Tal Slonim Buy +463,752 $9.28 $4,303,618 Exercise of options
07/12/21 Tal Slonim Exercise 463,752 $9.28 $4,303,618 Exercise of options
07/12/21 David Groberman Buy +463,752 $9.28 $4,303,618 Exercise of options
07/12/21 David Groberman Exercise 463,752 $9.28 $4,303,618 Exercise of options
07/12/21 Ronald (Ron) Weinberger Buy +100,000 $0.250 $25,000 Exercise of options
07/12/21 Ronald (Ron) Weinberger Exercise 100,000 $0.250 $25,000 Exercise of options
03/08/20 Ronald (Ron) Weinberger Buy +286,000 $0.094 $26,741 On-market trade
20/07/20 David Hinton Buy +333,333 $0.090 $30,000 Participation in share purchase plan
28/11/19 Tal Slonim Issued 1,249,695 $0.185 $231,194 As advised by the company
28/11/19 David Groberman Issued 1,249,695 $0.185 $231,194 As advised by the company

Director Interests

The current holdings of HMD directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
David Hinton 28/03/2024 N/A 430,000 N/A N/A
Timothy (Tim) Chapman 11/03/2024 N/A 277,778 10,691,666 N/A
Ronald (Ron) Weinberger 09/10/2023 801,000 N/A 7,500,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Mar 2, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Citicorp Nominees Pty Limited 12,187,408 5.02%
Altshuler Shaham Trusts Ltd <Holley Pharma Co Ltd A/C> 10,857,385 4.47%
Altor Capital Management Pty Ltd <Altor Alpha Fund A/C> 10,628,875 4.38%
Freeman Road Pty Ltd <The Avenue A/C> 10,543,779 4.35%
Altshuler Shaham Trusts Ltd <David Groberman A/C> 9,709,170 4.00%
Altshuler Shaham Trusts Ltd <Tal Slonim A/C> 9,709,170 4.00%
HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED 8,294,621 3.42%
S & S Browne Assets Pty Ltd <S & S Browne Investment A/C> 4,096,616 1.69%
Ratdog Pty Ltd 3,670,000 1.51%
Bryntirion Capital 3,637,273 1.50%
Ripperday Pty Ltd 3,457,496 1.42%
Chris Ntoumenopoulos 3,025,000 1.25%
Tamorer Pty Ltd <Wylie Family A/C> 2,909,091 1.20%
Mayo Clinic 2,767,691 1.14%
Mr Alan Jonathan Berrick 2,552,273 1.05%
Dr Matthew Farrugia 2,354,014 0.97%
Netwealth Investments Limited <Wrap Services A/C> 2,171,276 0.89%
Cardup Syndicate Holdings Pty Ltd <The Cardup Syndicate A/C> 2,050,000 0.84%
Mr John Vieira & Mrs Tracey Lois Vieira <Bayview Retirement Plan A/C> 1,656,000 0.68%
Dr Stuart Lloyd Phillips & Mrs Fiona Jane Phillips <Sl & Fj Phillips Pension A/C> 1,585,000 0.65%
North of the River Investments Pty Ltd 1,508,042 0.62%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Citicorp Nominees Pty Ltd 02/03/2023 12,187,408 5.02

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.065 30 June
2022 $0.097 30 June
2021 $0.285 30 June
2020 $0.087 30 June
2019 $0.190 28 June
HMD Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.